161 related articles for article (PubMed ID: 27860539)
21. Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Nov; 97(11):3974-82. PubMed ID: 22948755
[TBL] [Abstract][Full Text] [Related]
22. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
24. Markers of immune activation: novel biomarkers to predict the early-warning indicator of patients with papillary thyroid carcinoma.
Lu H; Zhang L; Dai Y; Ruan Y; Cao X; Cai X; Ruan S; Chen Q
Diagn Pathol; 2020 Feb; 15(1):16. PubMed ID: 32050977
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
[TBL] [Abstract][Full Text] [Related]
26. Coexistence of chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Impact on presentation, management, and outcome.
Dobrinja C; Makovac P; Pastoricchio M; Cipolat Mis T; Bernardi S; Fabris B; Piscopello L; de Manzini N
Int J Surg; 2016 Apr; 28 Suppl 1():S70-4. PubMed ID: 26708864
[TBL] [Abstract][Full Text] [Related]
27. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
28. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Liu Y; Yun X; Gao M; Yu Y; Li X
Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
[TBL] [Abstract][Full Text] [Related]
29. Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.
Voutsas IF; Anastasopoulou EA; Tzonis P; Papamichail M; Perez SA; Baxevanis CN
J Immunother Cancer; 2016; 4():75. PubMed ID: 27891225
[TBL] [Abstract][Full Text] [Related]
30. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
[TBL] [Abstract][Full Text] [Related]
32. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
33. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 Jan; 23(1):27-34. PubMed ID: 26598713
[TBL] [Abstract][Full Text] [Related]
34. Is diffuse and peritumoral lymphocyte infiltration in papillary thyroid cancer a marker of good prognosis?
Villagelin DG; Santos RB; Romaldini JH
J Endocrinol Invest; 2011 Dec; 34(11):e403-8. PubMed ID: 21765238
[TBL] [Abstract][Full Text] [Related]
35. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
[TBL] [Abstract][Full Text] [Related]
36. Association of HLA-B*51:01 with papillary thyroid carcinoma in the Chinese Han population of the Shandong coastal areas.
Shuxian J; Xiaoyun C; Zhihui F; Xiaohua L; Zhanhui D; Bin H; Lin Z
Thyroid; 2014 May; 24(5):867-71. PubMed ID: 24308748
[TBL] [Abstract][Full Text] [Related]
37. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
[TBL] [Abstract][Full Text] [Related]
38. [Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].
Chen R; Wei T; Zhang M; Li JQ; Zou XH; Fu BH; Wang LP; Peng YL; Ma BY; Zhu JQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):662-7. PubMed ID: 23141398
[TBL] [Abstract][Full Text] [Related]
39. HLA-G 3' untranslated region polymorphic sites associated with increased HLA-G production are more frequent in patients exhibiting differentiated thyroid tumours.
de Figueiredo-Feitosa NL; Martelli Palomino G; Cilião Alves DC; Mendes Junior CT; Donadi EA; Maciel LM
Clin Endocrinol (Oxf); 2017 Apr; 86(4):597-605. PubMed ID: 27914217
[TBL] [Abstract][Full Text] [Related]
40. Infiltration of Lynch colorectal cancers by activated immune cells associates with early staging of the primary tumor and absence of lymph node metastases.
de Miranda NF; Goudkade D; Jordanova ES; Tops CM; Hes FJ; Vasen HF; van Wezel T; Morreau H
Clin Cancer Res; 2012 Mar; 18(5):1237-45. PubMed ID: 22261803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
